About Myonex

In 1865, William Camm opened a Drug Store in Norristown, PA, USA. Almost 30 years later, A.A. Myers purchased the business and changed the name to Myers Drug Store.

In 1918, an 11-year-old Morris Cohen helped to deliver medications to patients stricken by the Spanish flu. Morris continued to work while completing his education which included a pharmacy degree. When Mr. Myers passed away in 1931, Morris acquired the store and continued to serve the Norristown community. Over the years, Myers Drug Store grew into a family-run business with his son Robert and then his grandson Michael joining him. With these additions, the company evolved into a clinical trial supply business known as Myoderm.

Since 2002 the company has grown in the US and subsequently in the UK and across Europe.

In 2009, a new GMP warehouse and offices were built in Norristown. Myoderm Ltd in the UK was established as a registered company in January 2011. In January 2012, Myoderm Ltd hired its first full-time employee in Leicester and from there continued to grow the staff in all areas of the business.

In February 2017, Myoderm reached a major milestone for the company with the opening of the new state of the art GMP facility in Leicester, UK. In September 2020, Myoderm became Myonex, the global Clinical Trial Supply Partner and a year later, a brand new, state of the art facility opened in Horsham, PA, USA the new home of Myonex LLC.

Two years later, in September 2022, Myonex acquired the Hubertus Pharmacy clinical trial business facility in Berlin, Germany, right in the heart of the European Union.

In 2024, Myonex expanded its business by acquiring SaveWay, a compounding pharmacy based in Newark, Delaware, USA, and increased its European footprint with the purchase of Creapharm headquartered in France with a wide range of services from Clinical Supply and Commercial Packaging to Bioservices.